SPDR S&P Biotech ETF
756 hedge funds and large institutions have $9.15B invested in SPDR S&P Biotech ETF in 2024 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 252 increasing their positions, 254 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $9.75B → $9.15B (-$594M)
22% less funds holding in top 10
Funds holding in top 10: 23 → 18 (-5)
46% less call options, than puts
Call options by funds: $1.59B | Put options by funds: $2.95B
Holders
756
Holding in Top 10
18
Calls
$1.59B
Puts
$2.95B
Top Buyers
| 1 | +$415M | |
| 2 | +$192M | |
| 3 | +$151M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$124M |
| 5 |
Two Sigma Advisers
New York
|
+$33.6M |
Top Sellers
| 1 | -$172M | |
| 2 | -$145M | |
| 3 | -$136M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$117M |
| 5 |
Morgan Stanley
New York
|
-$82.6M |